**Core Concept**
The underlying principle being tested is the management of convergent squint, also known as esotropia, in children. **Refraction** and **cycloplegia** are crucial in assessing and treating this condition.

**Why the Correct Answer is Right**
Since the correct answer is not provided, I will give a general explanation. In children with convergent squint, **cycloplegic refraction** is essential to determine the full refractive error. A commonly used cycloplegic agent for this purpose is **atropine**, due to its long-acting effect, which allows for accurate assessment of refractive error.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option, it's challenging to provide a detailed explanation. However, incorrect options might include drugs that are not suitable for cycloplegic refraction in children.
**Option B:** Similarly, without the specific option, it's hard to comment. But typically, options that are not **cycloplegic agents** would be incorrect.
**Option C:** Again, lacking the specific option, but usually, any drug that doesn't provide adequate cycloplegia for refraction purposes would be wrong.
**Option D:** This would be incorrect if it's not a suitable **cycloplegic** agent for children.

**Clinical Pearl / High-Yield Fact**
In clinical practice, **atropine** is often used for cycloplegic refraction in children due to its effectiveness and long duration of action. It's crucial for accurate assessment and management of refractive errors and squint.

**Correct Answer:** Correct Answer: D. Atropine.